Related Experiment Videos

[Medical-economic evaluation of bronchial cancer]

A Vergnenegre¹

¹Service de l'Information Médicale et de l'Evaluation, CHU de Limoges.

Revue Des Maladies Respiratoires

|March 24, 1999

Abstract

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Patients with non-small-cell lung cancer harbouring a BRAF mutation: a multicentre study exploring clinical characteristics, management, and outcomes in a real-life setting: EXPLORE GFPC 02-14.

Current oncology (Toronto, Ont.)·2018

Management of malignant pleural mesothelioma: a French multicenter retrospective study (GFPC 0802 study).

BMC cancer·2015

Impact of Continuing First-Line EGFR Tyrosine Kinase Inhibitor Therapy Beyond RECIST Disease Progression in Patients with Advanced EGFR-Mutated Non-Small-Cell Lung Cancer (NSCLC): Retrospective GFPC 04-13 Study.

Targeted oncology·2015

Two biomarker-directed randomized trials in European and Chinese patients with nonsmall-cell lung cancer: the BRCA1-RAP80 Expression Customization (BREC) studies.

Annals of oncology : official journal of the European Society for Medical Oncology·2014

Randomized open-label non-comparative multicenter phase II trial of sequential erlotinib and docetaxel versus docetaxel alone in patients with non-small-cell lung cancer after failure of first-line chemotherapy: GFPC 10.02 study.

Lung cancer (Amsterdam, Netherlands)·2014

Real-world healthcare resource utilization in a European non-small cell lung cancer population: the EPICLIN-Lung study.

Current medical research and opinion·2013

See all related articles